AP2015008525A0 - Transdermal delivery system - Google Patents

Transdermal delivery system

Info

Publication number
AP2015008525A0
AP2015008525A0 AP2015008525A AP2015008525A AP2015008525A0 AP 2015008525 A0 AP2015008525 A0 AP 2015008525A0 AP 2015008525 A AP2015008525 A AP 2015008525A AP 2015008525 A AP2015008525 A AP 2015008525A AP 2015008525 A0 AP2015008525 A0 AP 2015008525A0
Authority
AP
ARIPO
Prior art keywords
delivery system
transdermal delivery
transdermal
delivery
Prior art date
Application number
AP2015008525A
Other languages
English (en)
Inventor
Gabriel Wauer
Kevin John Smith
Gillian Elizabeth Mundin
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49816915&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP2015008525(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of AP2015008525A0 publication Critical patent/AP2015008525A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AP2015008525A 2012-12-12 2013-12-12 Transdermal delivery system AP2015008525A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261736342P 2012-12-12 2012-12-12
PCT/EP2013/076325 WO2014090921A1 (en) 2012-12-12 2013-12-12 Transdermal delivery system

Publications (1)

Publication Number Publication Date
AP2015008525A0 true AP2015008525A0 (en) 2015-06-30

Family

ID=49816915

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2015008525A AP2015008525A0 (en) 2012-12-12 2013-12-12 Transdermal delivery system

Country Status (26)

Country Link
US (3) US20150306093A1 (enExample)
EP (1) EP2931263A1 (enExample)
JP (1) JP2016502989A (enExample)
KR (1) KR20150096460A (enExample)
CN (1) CN105007906A (enExample)
AP (1) AP2015008525A0 (enExample)
AR (1) AR093940A1 (enExample)
AU (1) AU2013205080B2 (enExample)
BR (1) BR112015013660A2 (enExample)
CA (1) CA2894960A1 (enExample)
CL (1) CL2015001577A1 (enExample)
CR (1) CR20150360A (enExample)
DE (1) DE112013005945T5 (enExample)
EA (1) EA201591124A1 (enExample)
GB (1) GB2523715A (enExample)
HK (1) HK1215677A1 (enExample)
IL (1) IL239223A0 (enExample)
MX (1) MX2015007348A (enExample)
NZ (1) NZ628092A (enExample)
PE (1) PE20151147A1 (enExample)
PH (1) PH12015501169A1 (enExample)
SG (1) SG11201504286VA (enExample)
TN (1) TN2015000201A1 (enExample)
TW (1) TW201438765A (enExample)
WO (1) WO2014090921A1 (enExample)
ZA (1) ZA201504964B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006054731B4 (de) 2006-11-21 2013-02-28 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie
EP2790685B1 (en) 2011-12-12 2017-08-16 LTS LOHMANN Therapie-Systeme AG Transdermal delivery system comprising buprenorphine
LT2810646T (lt) 2013-06-04 2016-10-25 Lts Lohmann Therapie-Systeme Ag Transderminė tiekimo sistema
SG11201707350TA (en) 2015-03-10 2017-10-30 Rhodes Tech Acetate salt of buprenorphine and methods for preparing buprenorphine
EP3349737A4 (en) * 2015-09-14 2019-05-15 Amneal Pharmaceuticals LLC SYSTEM FOR TRANSDERING
KR101695603B1 (ko) * 2016-11-08 2017-01-12 이창우 병목 하단 밀착 구조의 점탄성 연결캡을 포함하는 니들 디스크 롤러 장치
WO2019064026A1 (en) 2017-09-29 2019-04-04 Orexo Ab NEW PHARMACEUTICAL COMPOSITIONS
BR112020018607A2 (pt) * 2018-03-13 2020-12-29 Lts Lohmann Therapie-Systeme Ag Sistema terapêutico transdérmico compreendendo um polímero híbrido de silicone acrílico
CA3092750A1 (en) * 2018-03-13 2019-09-19 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system for the transdermal administration of buprenorphine comprising a silicone acrylic hybrid polymer
WO2019175106A1 (en) * 2018-03-13 2019-09-19 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system comprising a silicone acrylic hybrid polymer
BR112020018300A2 (pt) * 2018-03-13 2020-12-22 Lts Lohmann Therapie-Systeme Ag Sistema terapêutico transdérmico compreendendo um polímero híbrido de silicone e acrílico
GB201904767D0 (en) 2019-04-04 2019-05-22 Orexo Ab New pharmaceutical compositions
CN114025748A (zh) * 2019-07-09 2022-02-08 罗曼治疗系统股份公司 包括包含含硅酮聚合物的含活性剂层和包含硅酮凝胶粘合剂的皮肤接触层的透皮治疗系统
CN113952319A (zh) * 2021-11-30 2022-01-21 烟台大学 一种含丁丙诺啡的骨架型透皮贴剂及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968547A (en) * 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
US7270830B2 (en) * 2002-12-13 2007-09-18 Purdue Pharma L.P. Transdermal buprenorphine dosage regimen for analgesia
CN1943576A (zh) * 2006-10-27 2007-04-11 哈尔滨健迪医药技术有限公司 丁丙诺啡和/或盐酸丁丙诺啡贴剂基质及其贴剂的制备方法
DE102006054731B4 (de) * 2006-11-21 2013-02-28 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie
CN101612141B (zh) * 2009-07-29 2012-10-03 考司美德制药株式会社 丁丙诺啡贴剂

Also Published As

Publication number Publication date
DE112013005945T5 (de) 2015-08-27
EA201591124A1 (ru) 2015-11-30
EP2931263A1 (en) 2015-10-21
WO2014090921A1 (en) 2014-06-19
US20150306093A1 (en) 2015-10-29
PH12015501169A1 (en) 2015-08-10
ZA201504964B (en) 2017-11-29
CA2894960A1 (en) 2014-06-19
HK1215677A1 (zh) 2016-09-09
GB201512243D0 (en) 2015-08-19
US20180193333A1 (en) 2018-07-12
NZ628092A (en) 2017-01-27
CN105007906A (zh) 2015-10-28
IL239223A0 (en) 2015-07-30
TW201438765A (zh) 2014-10-16
AU2013205080B2 (en) 2016-07-07
AR093940A1 (es) 2015-07-01
JP2016502989A (ja) 2016-02-01
US20200253957A1 (en) 2020-08-13
MX2015007348A (es) 2016-01-20
SG11201504286VA (en) 2015-06-29
KR20150096460A (ko) 2015-08-24
CR20150360A (es) 2015-08-21
GB2523715A (en) 2015-09-02
BR112015013660A2 (pt) 2017-07-11
TN2015000201A1 (en) 2016-10-03
AU2013205080A1 (en) 2014-06-26
CL2015001577A1 (es) 2015-10-02
PE20151147A1 (es) 2015-08-06

Similar Documents

Publication Publication Date Title
GB2512007B8 (en) Transdermal delivery system
GB201215193D0 (en) Order delivery system
ZA201509309B (en) Transdermal delivery system
GB2503668B (en) Delivery apparatus
IL217450A (en) Anti-rocket system
EP2806940A4 (en) SUPPLY UNIT
ZA201504964B (en) Transdermal delivery system
EP2858712A4 (en) RADIOPHARMACEUTICAL PRODUCT DELIVERY DEVICE
ZA201406682B (en) Transdermal delivery devices
GB201421723D0 (en) Delivery device
SMT201800030T1 (it) Sistema di erogazione transdermica
GB201213846D0 (en) Location system
GB201213491D0 (en) Content delivery system
GB201217418D0 (en) System
EP2904178A4 (en) RETENTION SYSTEM
ES3047535T3 (en) Multi-additive delivery system
EP2874940A4 (en) LIQUID DISTRIBUTION SYSTEM
ZA201405249B (en) Transdermal hormone delivery
SG11201405743QA (en) Liposomal delivery system
IL217432A0 (en) System
GB201214708D0 (en) Secure delivery system
ZA201301760B (en) Transdermal delivery devices
GB201108399D0 (en) Secure delivery system
GB201220312D0 (en) Passerelle system
GB201220319D0 (en) Passerelle system